From the Pharmacy Counter to the C-Suite: How Adesh Vora Is Reshaping Canadian Healthcare
Healthcare systems are often criticized for being fragmented — too many specialists, too many disconnected records, too little coordination between the people responsible for a patient's care. Few people understand that problem as intimately as Adesh Vora, a pharmacist-turned-entrepreneur who has spent the last decade building one of Canada's most ambitious answers to it: SRx Health Solutions.
A Pharmacist Who Saw the Cracks in the System
Before he was a CEO, Vora was on the front lines of Canadian healthcare, working as a pharmacist for more than twelve years. That vantage point gave him a close-up view of a fragmented system — one where doctors, pharmacists, nurses, dietitians, psychologists, physiotherapists, drug manufacturers, and clinics often operated in silos rather than in sync.
Rather than accept those gaps as the cost of doing business, Vora decided to build something different. In 2013, he founded SRx Health Solutions with a simple but ambitious premise: healthcare works better when the people delivering it are actually connected to one another.
What SRx Health Solutions Actually Does
Today, SRx has grown into one of Canada's largest collaborative networks of pharmacists and healthcare practitioners, with reach across all ten provinces. Its focus spans:
Specialty pharmacy services for patients managing chronic and rare diseases
Infusion services delivered in clinical and at-home settings
Patient support programs that guide people through complex treatment journeys
Clinical trials support for pharmaceutical partners
Manufacturer and physician support services that bridge the gap between drug developers and the clinicians prescribing their treatments
A recurring theme in how Vora describes the company is the idea of pushing pharmacists beyond their traditional dispensing role. SRx has invested in giving its pharmacists more clinical responsibility — optimizing treatment plans, catching drug interactions, and educating patients — while using automation to handle the administrative load so that human expertise gets spent where it matters most: with the patient.
Betting on Interoperability
One of the less glamorous but more consequential parts of SRx's strategy has been its investment in interoperability — the unglamorous plumbing that lets healthcare data move securely between providers. By building systems and health information exchange (HIE) networks that let patient data flow across platforms, SRx has tried to solve one of healthcare's oldest headaches: the fact that your pharmacist, your specialist, and your family doctor often can't see the same picture of your care.
This focus on technology-enabled coordination is part of why Healthcare Tech Outlook named SRx one of Canada's most promising healthcare tech services companies in 2023, spotlighting both Vora and COO Brock Clancy for their work integrating pharmacy expertise with modern data infrastructure.
A New Chapter: Going Public and a Leadership Shift
SRx's trajectory took a significant turn when Better Choice Company agreed to acquire SRx Health Solutions in an all-cash deal, bringing the specialty pharmacy network into the public markets under the ticker NYSE American: SRXH.
With that transition came a reshuffling at the top. In June 2025, the company announced a new leadership structure:
Lionel Conacher moved from Board member to Chairman of the Board
Adesh Vora transitioned from Executive Chairman to Chief Executive Officer
Kent Cunningham, the outgoing CEO, stepped into the role of President
Nina Martinez joined as Chief Financial Officer
Commenting on the changes, Vora framed them as a natural evolution rather than a disruption — an effort to strengthen governance and team structure in service of the company's long-term strategy. He pointed to a renewed focus on supporting patients with chronic and rare diseases, expanding infusion services, growing the clinical trials business, and deepening patient support programs.
Why It Matters
Vora's story is, in some ways, a familiar founder narrative: someone close to a broken process decides to fix it rather than complain about it. But what makes SRx notable is the scale of the ambition — trying to stitch together an entire national network of healthcare providers rather than solving one narrow piece of the puzzle.
As SRx moves further into the public markets and continues to expand its infusion, clinical trial, and patient support offerings, Vora's original thesis — that Canadian healthcare needed less fragmentation and more collaboration — is now being tested at a much bigger scale.
This post draws on public reporting from Healthcare Tech Outlook, SEC filings, HealthInsight Canada, and company statements.
Comments
Post a Comment